Hua Medicine (2552) Financial Statements

4 Followers

Hua Medicine Financial Overview

Hua Medicine's market cap is currently HK$3.27B. The company's EPS TTM is HK$1.1278; its P/E ratio is -9.58; Hua Medicine is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 480.18M	¥ 255.89M	¥ 76.61M	¥ 17.60M	¥ 0.00
Gross Profit	¥ 273.10M	¥ 124.72M	¥ 37.37M	¥ 7.69M	¥ 0.00
Operating Income	¥ -141.13M	¥ -352.64M	¥ -289.09M	¥ -267.12M	¥ -320.52M
EBITDA	¥ -109.50M	¥ -345.36M	¥ -167.09M	¥ -168.06M	¥ -309.69M
Net Income	¥ 1.08B	¥ -250.14M	¥ -211.23M	¥ -203.77M	¥ -330.95M
Balance Sheet
Cash & Short-Term Investments	¥ 1.09B	¥ 1.14B	¥ 1.46B	¥ 490.63M	¥ 675.24M
Total Assets	¥ 1.47B	¥ 1.53B	¥ 1.73B	¥ 1.12B	¥ 903.55M
Total Debt	¥ 301.80M	¥ 300.18M	¥ 167.75M	¥ 97.58M	¥ 71.53M
Net Debt	¥ -790.95M	¥ -839.57M	¥ -1.29B	¥ -393.05M	¥ -603.71M
Total Liabilities	¥ 463.48M	¥ 1.66B	¥ 1.62B	¥ 841.92M	¥ 453.22M
Stockholders' Equity	¥ 1.01B	¥ -135.47M	¥ 101.15M	¥ 279.58M	¥ 450.33M
Cash Flow
Free Cash Flow	¥ -59.70M	¥ -421.83M	¥ 879.52M	¥ -257.58M	¥ -339.87M
Operating Cash Flow	¥ -52.15M	¥ -417.97M	¥ 889.37M	¥ -230.11M	¥ -272.98M
Investing Cash Flow	¥ -654.00K	¥ 10.04M	¥ 8.08M	¥ -4.75M	¥ -68.22M
Financing Cash Flow	¥ 9.10M	¥ 83.72M	¥ 69.07M	¥ 21.48M	¥ -6.13M

Currency in CNY

Hua Medicine Earnings and Revenue History

Income Statement >

Hua Medicine Debt to Assets

Balance Sheet >

Hua Medicine Cash Flow

Cash Flow >

Hua Medicine Forecast EPS vs Actual EPS

Earnings >